Table 1. Basic characteristics of participants in in-depth interviews (N = 20).
| Participant | Age (years) | Maritalstatus | Career | Children | Cancer type | Number of yearssince diagnosis | Tumor size | Lymph node metastasis | Chemotherapy* | Hormonal therapy |
| Qian** | 42 | Married | Self-employed | 1 | Infiltrating ductal carcinoma | 2 | 2*2.5 | 2/24 | TH | Tamoxifen |
| Sun** | 38 | Married | Worker | 1 | Carcinoma in situ | 3 | 3*3 | 0/16 | X | No |
| Deng** | 43 | Married | Nurse | 1 | Infiltrating ductal carcinoma | 3 | 2.5*1.5 | 0/15 | EC | Tamoxifen |
| Liu** | 48 | Married | Bank staff | 1 | Infiltrating ductal carcinoma | 2 | 2*1 | 0/19 | TE | Tamoxifen |
| Huang** | 44 | Married | Worker | 1 | Infiltrating ductal carcinoma | 0.5 | 2*1.5 | 0/19 | EC-TX | No |
| Yin** | 36 | Married | Staff | 1 | Infiltrating ductal carcinoma | 2 | 2*2 | 0/19 | TH | Tamoxifen |
| Wang** | 37 | Married | Staff | 1 | Carcinoma in situ | 2 | 5*5 | 0/19 | TC | Tamoxifen |
| Xu** | 48 | Married | Worker | 1 | Infiltrating ductal carcinoma | 10 | NA | 0/20 | TE | Tamoxifen |
| Chen** | 47 | Married | Accountant | 1 | Infiltrating ductal carcinoma | 2 | 4.5*3.5 | 2/30 | TEC | Tamoxifen |
| Dai** | 38 | Married | Farmer | 2 | Infiltrating ductal carcinoma | 1 | 0.8*0.6 | 0/29 | FEC | No |
| Han** | 38 | Married | Unemployed | 1 | Infiltrating ductal carcinoma | 1 | 3.5*2 | 0/12 | TE | Tamoxifen |
| He** | 46 | Married | Unemployed | 1 | Infiltrating ductal carcinoma | 2 | 3*2 | 7/17 | TEC-FEC | Tamoxifen |
| Wang** | 40 | Married | Shop assistant | 1 | Infiltrating ductal carcinoma | 1 | 3*2 | 1/19 | TE | Tamoxifen |
| Wang** | 37 | Married | Unemployed | 1 | Infiltrating ductal carcinoma | 1 | 2.5*2 | 0/22 | TE | Tamoxifen |
| Liu** | 49 | Married | Worker | 1 | Infiltrating ductal carcinoma | 1 | 1.3*1 | 0/13 | CEX | Tamoxifen |
| Zong** | 48 | Married | Store keeper | 1 | Infiltrating ductal carcinoma | 0.5 | 1.5*1 | 0/14 | EC-T | Tamoxifen |
| Yang** | 48 | Married | Farmer | 2 | Infiltrating ductal carcinoma | 2 | 2.5*2.5 | 0/5 | FEC | No |
| Wan** | 48 | Married | Logistic staff | 1 | Infiltrating ductal carcinoma | 3 | 3*3 | 0/29 | TE | Tamoxifen |
| Lv** | 47 | Divorced | Unemployed | 1 | Infiltrating ductal carcinoma | 3 | 4*3 | 3/19 | TE | Tamoxifen |
| Ye** | 50 | Married | Accountant | 1 | Infiltrating ductal carcinoma | 4 | 2.5*2.5 | 2/17 | NE | Tamoxifen & Goserelin |
*
T: Docetaxel; X: Capecitabine; E: Epirubicin; C: Cyclophosphamide; H: Trastuzumab; F: Fluorouracil; N: Vinorelbine.